University of Arkansas

Razorback® Softball Pitcher Hannah Camenzind Takes the Mound in ZIPS "Car Wash Convos™"

Retrieved on: 
Tuesday, April 23, 2024

FAYETTEVILLE, Ark., April 23, 2024 /PRNewswire/ -- ZIPS Car Wash (zipscarwash.com) released its final Razorback episode today in Season 2 of "Car Wash Convos™" featuring University of Arkansas Softball's sophomore pitcher, Hannah Camenzind .

Key Points: 
  • FAYETTEVILLE, Ark., April 23, 2024 /PRNewswire/ -- ZIPS Car Wash (zipscarwash.com) released its final Razorback episode today in Season 2 of "Car Wash Convos™" featuring University of Arkansas Softball's sophomore pitcher, Hannah Camenzind .
  • Hannah's twin, Lauren, was featured in March with host Taliyah Brooks, University of Arkansas alumni and track & field star for the Razorbacks.
  • Visit the App Store or Google Play from your mobile device and search 'ZIPS Car Wash' to start earning wash rewards and app-only deals.
  • Plus, win big with a free wash just for joining.

NEW STUDY FINDS PRIVATE SCHOOLS ARE MORE EFFECTIVE AT BOOSTING KEY CIVIC OUTCOMES

Retrieved on: 
Tuesday, April 16, 2024

NEW YORK, April 16, 2024 /PRNewswire/ -- Private schools are linked to more positive civic outcomes for students and parents than public schools, according to a peer-reviewed statistical meta-analysis published today in Educational Psychology Review by authors from the University of Buckingham and University of Arkansas. The research, which combines, audits, and analyzes all available empirical studies of the effects of public and private schools on various civic outcomes, found that private schooling is associated with an advantage of 5.5 percent of a standard deviation, or roughly two percentile points, over public schooling in various measures of civic outcomes.

Key Points: 
  • "Since public schools were often established specifically to prepare children for citizenship, one might assume that they're superior to private schools at that function.
  • The study, titled "The Public Purposes of Private Education: a Civic Outcomes Meta‑Analysis," found that religious private schools had a greater effect than secular private schools relative to public schools, equivalent to 7.6 percent of a standard deviation.
  • "Educational pluralism, advanced by effective school choice policies, seems to be a boon, and not a bane, for civic outcomes."
  • For now, a wealth of evidence indicates that private schools do at least as well, and likely better, at forming democratic citizens.

The Wall Street Journal Launches Chief Compliance Officer (CCO) Council

Retrieved on: 
Wednesday, March 13, 2024

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- The Wall Street Journal has expanded its suite of leadership networks with the launch of a Chief Compliance Officer (CCO) Council .

Key Points: 
  • NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- The Wall Street Journal has expanded its suite of leadership networks with the launch of a Chief Compliance Officer (CCO) Council .
  • This exclusive, invitation-only international community will convene and connect the world’s most influential compliance leaders to discuss the issues shaping the increasingly complex risk landscape.
  • Representing a range of businesses and industries, founding members of the WSJ CCO Council include:
    Amanda Archibald, Chief Ethics and Compliance Officer, Equinor ASA
    Cindy Moehring, Founder, Executive Chair, Business Integrity Leadership Initiative, University of Arkansas, board member, former US Chief Ethics and Compliance Officer, Walmart
    Dr. Manuel Liatowitsch, Group General Counsel and Chief Legal Officer, Ringier AG
    Liz Atlee, SVP, Chief Ethics and Compliance Officer, CBRE
    Matt Miner, Executive Vice President, Global Chief Ethics and Compliance Officer, Walmart Inc.
    Nancy Grygiel, Senior Vice President, Worldwide Compliance and Business Ethics and Chief Compliance Officer, Amgen, Inc.
    Members will have access to trusted content, networking experiences, peer-to-peer knowledge sharing and a robust calendar of global events, including the inaugural CCO Council Summit taking place on May 2, 2024, in London.
  • It joins the Journal’s successful existing C-Suite executive memberships: the CEO Council, CFO Network, CIO Network and CMO Network.

Corgan and University of Arkansas Win AIA Upjohn Research Initiative Grant to Study ADHD and Workplace Design

Retrieved on: 
Tuesday, April 2, 2024

Global architecture and design firm Corgan , in partnership with the University of Arkansas, has received a research grant from the American Institute of Architects (AIA) Upjohn Research Initiative to study workplace design for neurodivergent people, specifically for those with ADHD.

Key Points: 
  • Global architecture and design firm Corgan , in partnership with the University of Arkansas, has received a research grant from the American Institute of Architects (AIA) Upjohn Research Initiative to study workplace design for neurodivergent people, specifically for those with ADHD.
  • Corgan—Hugo, the firm’s research and innovation group, will partner with the university on research with the goal of identifying successful inclusive design strategies.
  • Corgan will make the research insights accessible to designers all over the world via a workspace design guidebook in the spring 2025.
  • The AIA Upjohn Research Initiative supports research projects that enhance the value of design, funding up to six research grants annually.

Together, We Invest In The Next Generation And Shape The Future

Retrieved on: 
Tuesday, February 27, 2024

DALLAS, Feb. 27, 2024 /PRNewswire-PRWeb/ -- The Louise and Christopher B. Munday Foundation (The Munday Foundation) and 2020 Companies (https://www.2020companies.com) are delighted to announce the sixth round of their esteemed scholarship program, honoring 18 exceptional individuals who are dedicated to furthering their education. These scholarships are available to employees and their dependents enrolled full-time in 2-year or 4-year degree programs within the United States.

Key Points: 
  • These scholarships are available to employees and their dependents enrolled full-time in 2-year or 4-year degree programs within the United States.
  • This scholarship lifts the weight, fuels my passion, and empowers me to keep giving – both to myself and my community.
  • Continuing a Tradition of Educational Support:
    This Spring 2024 cycle marks another significant milestone – awarding 109 scholarships and investing in educational opportunities nationwide.
  • Empowering dreams and shaping futures, together, we invest in the next generation years to come.

Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program

Retrieved on: 
Tuesday, January 30, 2024

The compound, named HD-10019, is currently in pre-clinical development and is expected to commence IND-enabling studies in late 2024.

Key Points: 
  • The compound, named HD-10019, is currently in pre-clinical development and is expected to commence IND-enabling studies in late 2024.
  • HD-10019 is a type II kinase inhibitor that was rationally designed to overcome tyrosine kinase domain resistance mutations in the FLT3 kinase and improve myelosuppression versus standard of care agents for FLT3 mutated AML.
  • "We are excited to work with BioVentures and UCSF and take a step forward in delivering a novel treatment to FLT3 mutated AML patients," said Rayees Rahman, PhD, CEO of Harmonic Discovery.
  • Wilson Sonsini Goodrich & Rosati served as legal advisor to Harmonic Discovery on matters relating to the Licensing Agreement and related corporate and patent strategy matters.

Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting

Retrieved on: 
Wednesday, January 17, 2024

REDWOOD CITY, Calif., Jan. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HFX™ 10 kHz Therapy for patients with chronic pain. Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.

Key Points: 
  • Results will be presented at the 2024 North American Neuromodulation Society (NANS) Annual Meeting held from January 18-21, 2024 at Caesars Palace Las Vegas.
  • A total of 25 scientific abstracts reviewing clinical results for 10 kHz Therapy™, including four podium presentations and 21 posters, will be presented at the conference.
  • "The growing body of clinical evidence from our 25 scientific abstracts displays the substantial benefits of 10 kHz Therapy and we look forward to continuing to treat underserved patient populations suffering from debilitating chronic pain."
  • The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

David Reeder to Join Chewy as Chief Financial Officer

Retrieved on: 
Wednesday, December 6, 2023

Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, announced today the appointment of David Reeder as Chief Financial Officer (CFO), effective February 14, 2024.

Key Points: 
  • Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, announced today the appointment of David Reeder as Chief Financial Officer (CFO), effective February 14, 2024.
  • David joins Chewy from GlobalFoundries, Inc., a leading semiconductor manufacturer, where he has served as CFO since 2020 and led their financial strategy, including their 2021 initial public offering.
  • David previously served as Chief Executive Officer (CEO) of Tower Hill Insurance Group, as well as President and CEO of Lexmark International Inc.
  • Upon David’s arrival, interim CFO Stacy Bowman will continue serving as Chewy’s Chief Accounting Officer.

DELTA DENTAL OF ARKANSAS FOUNDATION AWARDS $1+ MILLION IN GRANTS

Retrieved on: 
Wednesday, November 15, 2023

SHERWOOD, Ark., Nov. 15, 2023 /PRNewswire/ -- In news befitting today's National Philanthropy Day, the Delta Dental of Arkansas Foundation awarded more than $1 million in grants to improve the oral health of Arkansans.

Key Points: 
  • Funding will support dental disease treatment & prevention, oral health education, systemic changes
    SHERWOOD, Ark., Nov. 15, 2023 /PRNewswire/ -- In news befitting today's National Philanthropy Day, the Delta Dental of Arkansas Foundation awarded more than $1 million in grants to improve the oral health of Arkansans.
  • The foundation board of directors approved almost $502,000 in 2024 Community Grants to 22 Arkansas nonprofits and schools, $60,000 in Oral Health Education Grants to two organizations, and close to $536,000 in Strategic Initiative Grants for three statewide projects.
  • The grants will deliver community-based oral health initiatives to tens of thousands of Arkansans, mainly low-income, uninsured or underinsured residents.
  • Delta Dental of Arkansas Foundation offers five grant programs for oral health projects.

Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board

Retrieved on: 
Monday, November 6, 2023

BERKELEY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) --  Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Sundar Jagannath, MD, to its scientific advisory board. With four decades of experience, Dr. Jagannath is a renowned expert in bone marrow transplantation and treating patients with multiple myeloma, and he is the director of the Center of Excellence for Multiple Myeloma at The Tisch Cancer Institute and professor of medicine, hematology and medical oncology, at Mount Sinai School of Medicine, New York.

Key Points: 
  • BERKELEY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Sundar Jagannath, MD, to its scientific advisory board .
  • “We are honored to have Dr. Jagannath join our scientific advisory board.
  • “Dr.
  • We urgently need such treatment options for patients living with relapsed or refractory multiple myeloma.”